Home/Oncovita/Jean-François Le Bigot
JL

Jean-François Le Bigot

Executive Chairman

Oncovita

Therapeutic Areas

Oncovita Pipeline

DrugIndicationPhase
MVdeltaCPleural MesotheliomaPre-clinical
Measovir®-based candidateBladder CancerPre-clinical
Measovir®-based Prophylactic Vaccine (with Unither)UndisclosedResearch/Pre-clinical